UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring

Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC–MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning

(2017) Arjen. M. Punt et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

LC–MS/MS method development for quantification of busulfan in human plasma and its application in pharmacokinetic study

(2016) Taraka Ramarao Nadella et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Repeat Analysis and Incurred Sample Reanalysis: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team

(2014) Eric Fluhler et al.   AAPS Journal

Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry

(2014) Soo Young Moon et al.   Annals of Laboratory Medicine

Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

(2011) Gheath Alatrash et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring

(2010) J. Gaziev et al.   BLOOD

Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry

(2010) Kamal M. Matar   CLINICA CHIMICA ACTA

A fast and simple assay for busulfan in serum or plasma by liquid chromatography–tandem mass spectrometry using turbulent flow online extraction technology

(2010) Dustin R. Bunch et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Busulfan in Hematopoietic Stem Cell Transplantation

(2009) Stefan O. Ciurea et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Busulfan in hematopoietic stem cell transplant setting

(2009) Jeannine S McCune et al.   Expert Opinion on Drug Metabolism & Toxicology

High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen

(2008) Michelle Geddes et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Therapeutic Drug Monitoring of Busulfan in Transplantation

(2008) J. Russell et al.   CURRENT PHARMACEUTICAL DESIGN